Significance of flavonoids targeting PI3K/Akt/HIF-1α signaling pathway in therapy-resistant cancer cells – a potential contribution to the predictive, preventive, and personalized medicine
Alena Mazurakova,Lenka Koklesova,Sandra Hurta Csizmár,Marek Samec,Aranka Brockmüller,Miroslava Šudomová,Kamil Biringer,Erik Kudela,Martin Pec,Samson Mathews Samuel,Monika Kassayova,Sherif T.S. Hassan,Karel Smejkal,Mehdi Shakibaei,Dietrich Büsselberg,Luciano Saso,Peter Kubatka,Olga Golubnitschaja
DOI: https://doi.org/10.1016/j.jare.2023.02.015
IF: 12.822
2023-03-05
Journal of Advanced Research
Abstract:Highlights • Paradigm shift from reactive to 3P medicine in essential in cancer management. • Natural substances are characterized by potent anticancer effects in primary and secondary care. • Working hypothesis proposes HIF-1α pathways to target by flavonoids against cancer resistance. • Clinically relevant example: individuals with the Flammer (FS) syndrome phenotype. • In FS ischemic-reperfusion is "at the crossroads" of signaling linked to HIF-1α pathways. • Economy relevant innovation is cost-effective prevention of the health-to-disease transition. Background Cancer management faces multiple obstacles, including resistance to current therapeutic approaches. In the face of challenging microenvironments, cancer cells adapt metabolically to maintain their supply of energy and precursor molecules for biosynthesis and thus sustain rapid proliferation and tumor growth. Among the various metabolic adaptations observed in cancer cells, the altered glucose metabolism is the most widely studied. The aberrant glycolytic modification in cancer cells has been associated with rapid cell division, tumor growth, cancer progression, and drug resistance. The higher rates of glycolysis in cancer cells, as a hallmark of cancer progression, is modulated by the transcription factor hypoxia inducible factor 1 alpha (HIF-1α), a downstream target of the PI3K/Akt signaling, the most deregulated pathway in cancer. Aim of Review: We provide a detailed overview of current, primarily experimental, evidence on the potential effectiveness of flavonoids to combat aberrant glycolysis-induced resistance of cancer cells to conventional and targeted therapies. The manuscript focuses primarily on flavonoids reducing cancer resistance via affecting PI3K/Akt, HIF-1α (as the transcription factor critical for glucose metabolism of cancer cells that is regulated by PI3K/Akt pathway), and key glycolytic mediators downstream of PI3K/Akt/HIF-1α signaling (glucose transporters and key glycolytic enzymes). Key Scientific Concepts of Review: The working hypothesis of the manuscript proposes HIF-1α – the transcription factor critical for glucose metabolism of cancer cells regulated by PI3K/Akt pathway as an attractive target for application of flavonoids to mitigate cancer resistance. Phytochemicals represent a source of promising substances for cancer management applicable to primary, secondary, and tertiary care. However, accurate patient stratification and individualized patient profiling represent crucial steps in the paradigm shift from reactive to predictive, preventive, and personalized medicine (PPPM / 3PM). The article is focused on targeting molecular patterns by natural substances and provides evidence-based recommendations for the 3PM relevant implementation. Graphical abstract Download : Download high-res image (146KB) Download : Download full-size image
multidisciplinary sciences